Current description of osteoarthritis includes the involvement of synovial inflammation. Studies contributing to understanding the mechanisms of cross-talk and feedback among the joint tissues could be relevant to the development of therapies that block disease progression. During osteoarthritis, synovial fibroblasts exposed to anomalous mechanical forces and an inflammatory microenvironment release factors such as a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) metalloproteinases that mediate tissue damage and perpetuate inflammation. We therefore studied the production of ADAMTS by synovial fibroblasts and their contribution to cartilage degradation. Moreover, we analyzed the implication of two mediators present in the osteoarthritis joint, IL-1b as proinflammatory cytokine, and 45-kDa fibronectin fragments as products of matrix degradation. We reported that synovial fibroblasts constitutively express and release ADAMTS 4, 5, 7, and 12. Despite the contribution of both mediators to the stimulation of Runx2 and Wnt/b-catenin signaling pathways, as well as to ADAMTS expression, promoting the degradation of aggrecan and cartilage oligomeric matrix protein from cartilage, fibronectin fragments rather than IL-1b played the major pathological role in osteoarthritis, contributing to the maintenance of the disease. Moreover, higher levels of ADAMTS 4 and 7 and a specific regulation of ADAMTS-12 were observed in osteoarthritis, suggesting them as new potential therapeutic targets. Therefore, synovial fibroblasts provide the biochemical tools to the chronicity and destruction of the osteoarthritic joints. (Am J Pathol 2016, -: 1e13; http:// dx
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Osteoarthritis (OA)
, one of the leading causes of substantial physical and psychological disability worldwide, is a complex disease with a prevalence of >70% in the population >55 years. 1, 2 Current description of OA includes not only the remodeling of articular cartilage and adjacent bone, but also the involvement of synovial inflammation, which is characterized by thickening of synovium or, indirectly, by joint effusion. Synovial membrane inflammation and proliferation 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 in OA joints trigger the production of cytokines and proteinases that damage connective tissues, including the cartilage. 3, 4 In this sense, research on inhibitory mediators of synovial activation could identify ways to avoid the progressive cartilage degradation and functional impairment. The role of synovial fibroblasts (SFs) as active drivers of joint destruction in rheumatoid arthritis is well established, 5 but their behavior in healthy subjects and OA patients is poorly understood. It has been described that OA-SF exposed to anomalous mechanical forces and to an inflammatory microenvironment, release factors such as a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS), that mediate tissue damage and perpetuate inflammation. 2,6e9 Therefore, studies contributing to a better understanding of the cross-talk and feed-back mechanisms among the joint tissues could be relevant to the development of new therapies able to block disease progression.
Our aim was to elucidate the role of SF in the cartilage joint degradation in OA patients through the production of ADAMTS and to characterize these metalloproteinases in HD
Q7
-SF. We have mapped the expression and function of aggrecanases ADAMTS 4 and 5, which degrade aggrecan, one of the main components of the cartilage extracellular matrix (ECM) that facilitates cartilage to resist compression. 10 We have also characterized ADAMTS 7 and 12, involved in destruction of cartilage oligomeric matrix protein (COMP), a noncollagenous component of the cartilage ECM that contributes to its assembly and to the cartilage integrity. 11 Moreover, we studied the physiopathological effect of two mediators present in OA joint microenvironment: the catabolic cytokine IL-1b and the 45-kDa fibronectin fragments (Fn-fs) as products of cartilage ECM degradation.
12e15 This study is the first to report the expression and release of ADAMTS 7 and 12 by SF from HD and OA patients, both constitutively and after IL-1b or Fn-fs stimulation. Besides, the capacity of SF to attach and degrade the cartilage ECM, generating glycosaminoglycans (GAGs) and releasing COMP, is also described. Finally, we study the activation of Runx2 and b-catenin, two signaling pathways related to ADAMTS expression. 16e18 Our study reports that SF activated by mediators present in the joint, such as a proinflammatory cytokines and Fn-fs, release ADAMTS, which contribute to the maintenance of cartilage destruction in osteoarthritic patients.
Materials and Methods

Patients and Synovial Fibroblast Cultures
Synovial tissue was obtained from 20 active OA patients (16 women and 4 men) aged between 48 and 87 years, at the time of knee prosthetic replacement surgery. Patients had advanced disease and were diagnosed with primary OA, excluding trauma, inflammatory disease, and other structural causes of secondary OA. Control samples from HD were obtained from four patients (two women and two men) aged between 35 and 72 years, at the time of knee arthroscopic evaluation. These patients were diagnosed with meniscopathy caused by trauma to the knee or sports injury, excluding inflammatory and rheumatic diseases. The study was performed according to the recommendations of the Declaration of Helsinki and approved by the Clinical Research Ethics Committee of the Hospital La Princesa (Madrid, Spain). All biopsy samples were obtained after subjects gave informed consent. SF cultures were established by explant growth of synovial biopsies, cultured in Dulbecco's modified Eagle's medium (DMEM) with 25 mmol/L Q8 HEPES and 4.5 g/L glucose, completed with 10% heat-inactivated fetal bovine serum (Lonza Ibérica S.A.U., Barcelona, Spain), 1% L-glutamine, and 1% antibiotic-antimycotic (Invitrogen, Carlsbad, CA) at 37 C and 5% CO 2 . After three passages, residual contamination by macrophages was avoided, previously assessed by flow cytometry analysis of SF with a purity of 95%. 19 Monocultures of SF were used for experiments until passage 8. Despite the use of cells at varying passage numbers, all comparisons within a same experimentation were made on SF at an identical passage number and at 80% to 90% confluence.
For treatments, HD-and OA-SF were cultured in serumfree DMEM with 1% L-glutamine and 1% antibioticantimycotic, in the absence (untreated) or presence of the following agents: 10 ng/mL IL-1b (ImmunoTools 
RNA Extraction and Quantitative RT-PCR
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for ADAMTS Gene Expression
SFs were seeded in 100-mm petri dishes (3 Â 10 5 cells per dish) and cultured in the absence or presence of 10 ng/mL IL1b or 10 nmol/L Fn-fs 45 kDa for 24 hours. Total RNA was obtained using TriReagent (Sigma-Aldrich). Two microgram of RNA was reverse transcribed using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Semiquantitative real-time PCR analysis was performed using a TaqMan Gene Expression Master Mix with manufactured-predesigned primers and probes for b-actin (NM001101.3), ADAMTS-4 (NM005099.4), ADAMTS-5 (NM007038.3), ADAMTS-7 (NM014272.3), and ADAMTS-12 (NM030955.2) (Applied Biosystems). We normalized the target gene expression to the housekeeping gene, b-actin (2 ÀDCt ). For relative quantification, results were presented as the relative expression with respect to the untreated condition using the formula 2 ÀDDCt , as previously described. 19 
Quantification of ADAMTS in Culture Supernatants
SFs were seeded in 6-well plates (6 Â 10 4 cells per well) and cultured in the absence or presence of 10 ng/mL IL-1b or 10 nmol/L Fn-fs 45 kDa, for 24 hours. Levels of ADAMTS were measured in the culture supernatants using commercial enzyme-linked immunosorbent assay (ELISA) kits for 125  126  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187 ADAMTS 4 and 5 (Cloud-Clone Corp., Houston, TX), and for ADAMTS 7 and 12 (MyBioSource, San Diego, CA).
Aggrecanase Activity Assay
SFs were seeded in 100-mm petri dishes (3 Â 10 5 cells per dish) and cultured in the absence or presence of 10 ng/mL IL-1b or 10 nmol/L Fn-fs 45 kDa, for 24 hours. Aggrecanase activity was measured in the SF culture supernatants using a Sensitive Aggrecanase Activity ELISA Kit (MD Bioproducts, Zürich, Switzerland), according to the manufacturer's instructions. Briefly, this assay consists of two modules. In the Aggrecanase Module, a modified interglobular domain (aggrecan-IGD-s) is digested with aggrecanases, and its proteolytic cleavage releases an aggrecan peptide (ARGSVIL-peptide-s), which is then quantified with antibodies in the ELISA Module.
Immunocytochemistry
SFs were seeded on glass coverslips (2.5 Â 10 4 cells per glass), fixed with paraformaldehyde, and permeabilized with Tween-20 in phosphate-buffered saline. Cells were blocked with phosphate-buffered saline containing donkey serum and incubated with rabbit polyclonal anti-human antibodies for ADAMTS 4, 5, 7, or 12 (Sigma-Aldrich). After washing, cells were incubated with AlexaFluor 488 donkey anti-rabbit IgG antibody (Invitrogen). Coverslips were counterstained with Hoechst. Background fluorescence was reduced with Sudan Black in ethanol. Negative controls were performed in the absence of primary antibodies (data not shown). Fluorescence was examined using an Olympus BX51 microscope with DP72 camera model (objective 40Â).
Runx2 Assay
SFs were seeded in 150-mm petri dishes (8 Â 10 5 cells per dish). A Nuclear Extract Kit (Active Motif, Rixensart, Belgium) was used for nuclear extracts preparation, and the protein content was measured with a QuantiPro BCA Assay Kit (Sigma-Aldrich). Cytoplasmic extracts obtained were stored at À80 C for later use in the Western blots. Nuclear extracts (12 mg per well) were added to a 96-well plate, and Runx2 activity was measured using a TransAM AML-3/ Runx2 kit (Active Motif). Time course of Runx2 activation after incubation with 10 ng/mL IL-1b or 10 nmol/L Fn-fs 45 kDa was studied (data not shown), and the experiments were performed at 60 or 30 minutes of treatment, respectively.
b-Catenin Assay
To detect b-catenin levels, a b-catenin (Total) and a (Phospho) InstantOne ELISA kits were used (eBioscience, San Diego, CA) with SF cellular lysates. Briefly, SFs seeded in 100-mm petri dishes (3 Â 10 5 cells per dish) were scraped into phosphate-buffered saline, centrifuged, and resuspended in the Cell Lysis Buffer Mix (eBioscience). Protein content was measured by QuantiPro BCA Assay Kit. Levels of b-catenin in the cellular lysates were measured after 60 minutes of treatment with 10 ng/mL IL-1b or 10 nmol/L Fn-fs 45 kDa.
Western Blots
For the detection of ADAMTS, SFs were seeded in 100-mm dishes and cultured to confluence. Culture supernatants were collected. For protein purification and concentration, Amicon Ultra 0.5 mL centrifugal filters (Merck Millipore, Darmstadt, Germany) were used. For Runx2 and b-catenin, the cytoplasmic extracts previously obtained were used, and protein content was measured by QuantiPro BCA Assay Kit. Cytoplasmic extracts (15 mg/well) and culture supernatants were subjected to SDS-PAGE and blotted on a polyvinylidene difluoride membrane (Bio-Rad Laboratories, France 
Blockade Experiments
For blockade experiments, HD-and OA-SF were seeded in 100-mm dishes (3
Q13
. 10 5 cells per dish) and cultured in serumfree DMEM with 1% L-glutamine and 1% antibioticantimycotic, in the absence or presence of 10 mmol/L of MEK inhibitor, PD98059, consequently implicated in the inhibition of ERK-MAPK; 10 mmol/L of p38-MAPK inhibitor, SB203580 (Calbiochem, EMD Biosciences, San Diego, CA), or 200 ng/mL of Wnt inhibitor, DDK-1 (R&D Systems) for 1 hour. These treatments were followed by stimulation with 10 ng/mL IL-1b or 10 nmol/L Fn-fs 45 kDa, for 24 hours. Total RNA was obtained, and quantitative RT-PCR for ADAMTS 4 and 5 was performed as previously described
Q14
.
GAGs and COMP Assays in Cartilage-SF Co-Cultures
Release of GAG and COMP from cartilage was measured in culture supernatants from wells containing co-cultures of SF over cartilage explants. 20 OA human cartilages were obtained from three patients undergoing total hip arthroplasty from Hospital del Mar (Barcelona, Spain). Fixed diameter (6 mm) and height (2 mm) sections were collected from cartilage areas without macroscopic signs of OA. Samples
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The American Journal of Pathology -ajp.amjpathol.org 3   249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311   312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372 were frozen at À80 C and stored until testing. One explant per well was attached to a 24-well plate. HD-or OA-SF were added drop-wise on top of the cartilage surface (2 Â 10 4 SF per explant). After 3 hours of incubation, wells were filled with DMEM in the absence or presence of 10 ng/ mL IL-1b or 10 nmol/L Fn-fs 45 kDa, and cultures were continued for 14 days. Culture supernatants were collected for detection of GAG and COMP, using a Blyscan Sulfated Glycosaminoglycan Assay (Biocolor Ltd County Antrim, Ireland, UK), and a Quantikine Human COMP Immunoassay (R&D Systems, Abingdon, OX, UK), respectively. Frozen sections were prepared using a cryostat and stained with Alcian blue and Callejas's tricromic. Sections were observed using an Olympus BX51 microscope with DP72 camera model (objective 20Â).
Statistical Analysis
Data were analyzed using the GraphPad Prism software Q15 version 6. Data were subjected to normality test (Kolmogórov-Smirnov test) and equal variance test (F-test). Statistical differences between sample groups were assessed using Student's two-tailed t-test or unpaired t-test with Welch's correction, in case of groups with different variances. P < 0.05 was considered statistically significant. Results are presented as the means AE SEM. ). Patterns of constitutive ADAMTS gene expression were similar in untreated HD-and OA-SF. ADAMTS-5 was the most expressed followed by ADAMTS 4, 7, and 12. ADAMTS-5 transcripts were nearly 50-fold higher than ADAMTS-12. Comparing HD-and OA-SF, ADAMTS 4 and 7 transcripts were twofold and fourfold higher in OA-than in HD-SF, respectively. However, ADAMTS 5 and 12 mRNA levels were similar.
Results
SFs Express and
ADAMTS protein expression was confirmed by immunocytochemistry. Untreated HD-and OA-SF displayed similar morphology and both showed cytoplasmic immunostaining for ADAMTS 4, 5, 7, and 12 ( Figure 2 
½F2 ½F2
). No staining was observed in isotype controls (data not shown). 373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408  409  410  411  412  413  414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435   436  437  438  439  440  441  442  443  444  445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472  473  474  475  476  477  478  479  480  481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496 ADAMTS were also evaluated in untreated SF culture supernatants by Western blot (Figure 3 
½F3 ½F3
). We confirmed that all ADAMTS are released to the medium by HD-and OA-SF. Western blots for ADAMTS 4 
IL-1b and 45-kDa Fn-fs Enhance the Expression of ADAMTS-4 and ADAMTS-5 in SF
Because SF has been suggested to represent an important source of aggrecanases within the joint mediating cartilage destruction, 10 we next studied the effect of IL-1b and Fn-fs on their production. IL-1b and Fn-fs increased the transcript and protein of ADAMTS-4 in HD-and OA-SF compared with the untreated cells ( Figure 4 ½F4 ½F4 , A and B). A significant increase in ADAMTS-5 transcript and protein was detected in OA-SF for both stimuli, whereas in HD stimulation was only observed in the protein after treatment with IL-1b ( Figure 4, C and D) . Altogether, these results show that IL-1b increased ADAMTS 4 and 5 in HD-and OA-SF, whereas Fn-fs showed more specific effects in OA, resulting in a significant augment of ADAMTS-4 in both, and in a restricted stimulation of ADAMTS-5 production in OA-SF.
Aggrecanase Activity in SF and GAGs Release in Cartilage-SF Co-Cultures ADAMTS 4 and 5 cleave aggrecan within the interglobular domain at the Glu-373 and Ala-374 bond. 21, 22 Thus, we assessed the ability of ADAMTS 4 and 5 produced by cultured SF to this cleavage by measuring aggrecanase activation and the ARGSVL-peptide-s released in culture supernatants by means of ELISA.
Both the constitutive aggrecanase activity ( Figure 4E ) and the derived peptide (data not shown) were significantly 
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The American Journal of Pathology -ajp.amjpathol.org 5   497  498  499  500  501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559   560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594  595  596  597  598  599  600  601  602  603  604  605  606  607  608  609  610  611  612  613  614  615  616  617  618  619  620 greater in OA-compared to HD-SF. Fn-fs significantly increased aggrecanase activity ( Figure 4F ) and the derived peptide (data not shown) exclusively in OA-SF, whereas IL-1b did not induce any change. Interestingly, these results correlated with the Fn-fs induction of ADAMTS 4 and 5 in OA-SF. The aggrecanase activity yields the generation of GAGs from the aggrecan in cartilage ECM. Hence, we next studied the potential capacity of SF to degrade cartilage by measuring GAG release in supernatants from cartilage-SF co-cultures. After 14 days of in vitro co-cultures, a monolayer of SF was observed exclusively on the cartilage surface ( Figure 4G ). The effects of IL-1b and Fn-fs after 14 days of treatment were evaluated. The constitutive release of GAGs to the medium was significantly greater in OA-SF compared to HD-SF. IL-1b induced no change in GAGs levels, whereas Fn-fs enhanced significantly the release of GAGs in both HD-and OA-SF (Figure 4I ).
Runx2 and b-Catenin Activation in SF
Because Runx2 transcription factor and Wnt/b-catenin signaling are involved in aggrecanase gene expression, 16e18 and also seem to be implicated in the OA pathology, 23, 24 we decided to examine whether IL-1b or Fn-fs could alter the ADAMTS 4 and 5 expressions by the modulation of these factors.
Indeed, we found that both IL-1b and Fn-fs significantly induced nuclear activation of Runx2 in HD and OA-SF ( Figure 5 
½F5 ½F5
A), consistent with its reduction in the cytoplasm after the stimulation with both mediators ( Figure 5C ). Nonetheless, the data were consistent with a role for Runx2 ) in co-culture with OA-SF (arrow; G) and without SF (H). Alcian blue and Callejas's tricromic staining (objective, 20Â). I: Glycosaminoglycans (GAGs) in cartilage-SF co-culture supernatants after treatment with IL-1b or 45-kDa Fn-fs for 14 days were detected by a Blyscan Sulfated glycosaminoglycan assay. Values are from duplicate determinations. Dashed lines represent the untreated condition. Data are presented as means AE SEM (AeF and I). n Z 4 (AeF, HD); n Z 7 (AeD, OA); n Z 5 (E and F, OA); n Z 3 (I, HD and OA). *P < 0.05, **P < 0.01, and ***P < 0.001 treatment versus untreated; y P < 0.05 HD versus OA. 621  622  623  624  625  626  627  628  629  630  631  632  633  634  635  636  637  638  639  640  641  642  643  644  645  646  647  648  649  650  651  652  653  654  655  656  657  658  659  660  661  662  663  664  665  666  667  668  669  670  671  672  673  674  675  676  677  678  679  680  681  682  683 in ADAMTS4 transcription because the transcript abundance with IL-1b, on both HD and OA, was approximately twofold greater than in untreated controls. Furthermore, treatment with Fn-fs stimulated ADAMTS4 expression was approximately 2.5-fold in OA cells and approximately 1.3-fold in HD cells. In contrast to ADAMTS-4, ADAMTS-5 expression showed no stimulation of HD-SF by either IL-1b or Fn-fs, but approximately a 1.6-fold increase by both IL-1b and Fn-fs in OA.
In the cytoplasm, b-catenin is regulated by interaction with a multiprotein complex that phosphorylates it to be degraded by proteasomes. On activation of Wnt signaling, non-phosphorylated b-catenin is transported to the nucleus, where it couples with the complex T-cell factor/lymphoidenhancing factor to initiate the transcription of ADAMTS 4 and 5 genes. 25 We measured both b-catenin forms in cellular lysates of SF, where levels of phosphorylated bcatenin were undetectable by ELISA (data not shown). Thus, we measured the total b-catenin that mainly represented the active form.
The b-catenin content of whole cell lysates was approximately 1.5-fold higher for untreated OA-SF than untreated HD. Moreover, b-catenin levels increased to approximately twofold after treatment with either IL-1b or Fn-fs exclusively in OA ( Figure 5B ), which correlated with the reduction observed in cytosplasmic extracts by Western blot ( Figure 5D ).
To better elucidate the implication of Runx2 and b-catenin in the aggrecanases expression, we performed blockade experiments using inhibitors of two MAPK, ERK, and p38-MAPK, implicated in the activation of Runx2, PD98059, and SB203580, respectively. We also used an inhibitor of Wnt/b-catenin signaling, DDK-1. We showed that PD98059 significantly inhibited mRNA expression of ADAMTS-4 before treatment with IL-1b or Fn-fs, in HD-and OA-SF ( Figure 6 
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Induction of ADAMTS-7 and ADAMTS-12 by IL-1b or 45-kDa Fn-fs in SF, and COMP Production in Cartilage-SF Co-Cultures
We further studied the effects of IL-1b and Fn-fs on the ADAMTS involved in the degradation of COMP.
ADAMTS 7 and 12 share a C-terminal COMP/GEP-binding TSP domain. Their effects in OA are because of the association of this domain with COMP and its subsequent degradation. 26 Significant increases in ADAMTS-7 transcript and protein were detected after IL-1b and Fn-fs stimulation ( Figure 7 ½F7 ½F7 , A and B). Regarding ADAMTS-12, we observed an increase of mRNA and protein induced by both stimuli exclusively in OA-SF ( Figure 7, C and D) .
The release of COMP and its degradative fragments was measured in the culture supernatants after 14 days of treatment with IL-1b and Fn-fs ( Figure 7E ). The constitutive release of COMP was significantly greater in OA-SF than in HD. Moreover, significant increases were detected after IL-1b and Fn-fs stimulation. 869  870  871  872  873  874  875  876  877  878  879  880  881  882  883  884  885  886  887  888  889  890  891  892  893  894  895  896  897  898  899  900  901  902  903  904  905  906  907  908  909  910  911  912  913  914  915  916  917  918  919  920  921  922  923  924  925  926  927  928  929  930  931 Discussion ADAMTS metalloproteinases play key roles in cartilage homeostasis and in the pathogenesis of OA, where the disruption of this balance, in favor of proteolysis, leads to a pathological cartilage destruction. 3 ADAMTS 4, 5, 7, and 12 have been implicated in the breakdown of cartilage in OA, 27 ,28 ADAMTS 4 and 5 degrading aggrecan, and ADAMTS 7 and 12 degrading COMP. Although their functions are well understood in cartilage, few studies have addressed the contribution of SF to their expression and release.
We showed that ADAMTS-5 was the most expressed in both HD-and OA-SF. Although ADAMTS4 gene expression was higher in OA than in HD, ADAMTS-5 mRNA expression was similar in both. Despite the fact that the levels of ADAMTS-5 are higher, differences in the ADAMTS-4 expression between HD and OA-SF seem to indicate its involvement in the OA pathology. However, lower levels of ADAMTS 4 and 5 have been reported in OA cartilage and synovium compared with non-OA tissues. 29 Nevertheless, this discrepancy could be explained by the fact that whole synovium was used in their experiments. In addition, discordant data in the constitutive mRNA expression of ADAMTS 4 and 5 in non-OA and OA cartilage have been described, 10 likely because of the different stages of the disease.
The complexity of ADAMTS regulation, by both pretranscriptional and post-transcriptional mechanisms, which ultimately determine the levels of secreted enzymes, has been reported. 10 In this study, we demonstrated that both HD-and OA-SF release aggrecanases. Western blot analysis of ADAMTS 4 and 5 in SF culture supernatants revealed the presence of the active forms of both enzymes, between 48 and 74 kDa, similar to those reported in OA synovial fluids. 30 We also observed a major band between 74 and 114 kDa, which has been described as the ADAMTS-4 proenzyme, in cartilage from OA patients, 28 as well as in SF. 9 Regarding ADAMTS-5, other authors have also reported a 70-kDa form of ADAMTS-5 in cartilage, as well as in SF from OA patients, 9,28 that could represent different degradation fragments.
We reported that the aggrecanase activity and GAGs release are constitutively greater in OA than in HD. By contrast, no differences in the expression of aggrecanases between non-OA and OA synovium have been reported, 9, 31 with no data about their activity. Our results showed that IL-1b increased ADAMTS 4 and 5, with no impact in the . n Z 4 (AeD, HD); n Z 7 (AeD, OA); n Z 3 (E, HD and OA). *P < 0.05, **P < 0.01, and ***P < 0.001 treatment versus untreated; y P < 0.05 HD versus OA.
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The American Journal of Pathology -ajp.amjpathol.org 9 aggrecanase activity or GAGs production. Because the protein abundance of ADAMTS-4 is apparently influenced by the transcript, in both HD and OA, whereas the protein abundance of ADAMTS-5 after stimulation with IL-1b in HD does not correlate with the transcript, it seems likely that this ADAMTS is not the main aggrecanase. This fact corroborates other studies, which indicate that ADAMTS-5 mRNA levels do not correlate with the OA progression in chondrocytes, because of post-translational regulations. 32 A recent study reported that IL-1b induced expression of ADAMTS-4 in SF but did not measure the activity. 33 At the functional level, our results are in agreement with previous findings showing that ADAMTS 4 and 5 are not regulated by this cytokine in SF. 9, 12, 31 The role of IL-1b in OA is controversial, and the implication of other mediators, as cartilage ECM degradation products, seems to be more relevant in the pathology. 12 Despite that, the study of IL-1b, as a pleiotropic proinflammatory cytokine, also contributes to the knowledge of the mechanism involved in the disease. In addition, because synovial inflammation intensity is greater in OA initial stages, 4 the lack of effects observed in the aggrecanase activity after IL-1b stimulation could be explained by the advanced disease state of our patients. Although, after stimulation with IL-1b we observed effects in the levels of ADAMTS 4 and 5, they were not significant enough to promote their activity.
Articular cartilage matrix proteins are degraded in OA, resulting in the production of fragments with proinflammatory properties, including those of fibronectin. 34, 35 In chondrocytes, it has been described that the N-terminal Fnfs 45 kDa induces matrix metalloproteinases synthesis and aggrecan degradation 13, 14, 36 ; however, there are no data about its action in other joint cells. Herein, we describe for the first time the aggrecanases induction by Fn-fs in SF. Consistent with these previous reports
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, we noticed that Fn-fs produced a more specific effect in OA-SF, increasing aggrecanases production and activity, as well as cartilage degradation, evaluated by GAGs release from SF-cartilage co-cultures. Because ADAMTS-4 was also increased by Fn-fs in the co-cultures with HD-and OA-SF, these results again point to its main contribution to the aggrecan degradation. The integrin a5b1 is one of the main receptors implicated in the function of fibronectin, being involved in the cartilage proteoglycan degradation induced by the 45-kDa Fn-fs. 37, 38 a5b1 integrins are also expressed in RA-SF, showing a significant increase compared with normal SF. 39 Thus, SF from OA patients would synthetize aggrecanases after 45-kDa Fn-fs stimulation through integrins engagement. Our data suggest that in stages of SF hyperplasia in OA, Fn-fs could establish a feedback loop contributing to the maintenance of cartilage erosion.
Runx2 can be predicted to promote ADAMTS 4 and 5 transcription. 16, 17 A recent study implicated it in the expression of ADAMTS 7 and 12 in OA cartilage also. 24 On the other hand, Wnt/b-catenin signaling is a potent stimulator of chondrocyte matrix catabolic action triggering joint destruction, which also regulates aggrecanases expression. 18 Both signaling pathways seem to play important roles in the OA pathophysiology. 40e43 We showed that IL-1b and Fn-fs induced Runx2 in HD-and OA-SF. Moreover, ERK-and p38-MAPK are implicated in the activation of Runx2 transcription factor. 44e46 Blockade experiments showed that ERK-MAPK is involved in the expression of ADAMTS 4 and 5, stimulated by IL-1b or Fn-fs, in OA-SF. As both stimuli also induced the activation of Runx2 and the expression of both aggrecanases in these cells, we can conclude that ERK-MAPK signaling through Runx2 is involved in the expression of ADAMTS 4 and 5 in OA. ERK-MAPK also regulates the expression of ADAMTS-4 after both stimuli in HD-SF, in correlation with the induction of ADAMTS-4 transcript and protein, as well as with the activation of Runx2. These data suggest that IL-1b and Fn-fs could control ADAMTS-4 transcription via ERK-MAPK and Runx2 also in SF from HD, by contrast to ADAMTS-5. On the other hand, p38-MAPK is only implicated in the expression of ADAMTS-4 after Fn-fs induction in HD-and OA-FLS, as well as in the induction of ADAMTS-5 exclusively in OA-SF by both stimuli.
Of interest, we detected b-catenin induction exclusively in OA-SF, which also correlates with the restricted inhibition of Wnt signaling in OA-SF, mediated by DKK-1 before stimulation by both, IL-1b or 45-kDa Fn-fs, pointing to the implication of this signaling pathway in the OA pathology. These results are in agreement with the higher expression of Wnt responsive genes, such as WISP1, in OA, 47 which has been associated with a profibrotic and antichondrogenic OA-like phenotype. 48 This
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interpretation is further supported by the finding that the Wnt7a/b-catenin pathway promotes proteasomal degradation of Sox9, thereby blocking expression of chondrogenic genes. 49 These results could shed some light on the understanding of how synovitis is triggered in OA, which is an issue under exploration. The disruption of the articular cartilage matrix is the most differencing feature in OA, and the resulting fragments of ECM catabolism have been associated with inflammation through the triggering of Toll-like receptor signaling pathways. Both IL-1b and Fn-fs induced the expression of Toll-like receptor 2 in chondrocytes. 50 Thus, in addition to integrins, Fn-fs, as an endogenous ligand of Toll-like receptors 2 and 4, could act through its engagement, given that both receptors are present in SF. 48, 51 Moreover, both stimuli induce the activation of MAPK signaling, implicated in the activation of Runx2 and other transcription factors, such as the NF-kB, 13e15,46,52 which also induce the expression of Wnt. 53, 54 Therefore, we can hypothesize that IL-1b and 45-kDa Fn-fs induce aggrecanases expression by activation of the transcription factor Runx2, mainly through the ERK-MAPK signaling. Moreover, these stimuli specifically induce the Wnt/b-catenin signaling in OA-SF, with the consequent therapeutic value. 1117  1118  1119  1120  1121  1122  1123  1124  1125  1126  1127  1128  1129  1130  1131  1132  1133  1134  1135  1136  1137  1138  1139  1140  1141  1142  1143  1144  1145  1146  1147  1148  1149  1150  1151  1152  1153  1154  1155  1156  1157  1158  1159  1160  1161  1162  1163  1164  1165  1166  1167  1168  1169  1170  1171  1172  1173  1174  1175  1176  1177  1178  1179 OA compared with HD. Regarding other joint tissues, ADAMTS 7 and 12 mRNA expression have been previously described in whole synovium, with similar levels in OA and HD. 29 In the present study, we show, for the first time, that isolated SF express and release ADAMTS 7 and 12. ADAMTS-7 transcripts were higher in OA-than in HD-SF, whereas expression of ADAMTS-12 was similar in both. The higher expression of ADAMTS-7 in OA compared with HD also indicates the contribution of this ADAMTS in the OA pathology.
Our results are the first to describe the presence of ADAMTS 7 and 12 proteins in SF. Western blot of ADAMTS-7 showed a band between 114 and 201 kDa, similar to the active form previously described in a human kidney cell line. 55, 56 Regarding ADAMTS-12, we also reported a band between 114 and 201 kDa, equivalent to that previously reported in the same human line, 33 and a smaller band between 74 and 114 kDa that could represent the C-terminal fragment containing the TSP-1 repeats. 57, 58 As ADAMTS 7 and 12 are involved in the breakdown of arthritic articular cartilage, 56, 59 SFs represent other source of both metalloproteinases that would contribute to the maintenance of the cartilage damage. In this sense, COMP fragments have been identified in cartilage, synovial fluid, and serum from OA and rheumatoid arthritis patients. Moreover, increased levels of COMP in synovial fluid and serum are related to joint damage and progression in rheumatic diseases.
59e61 Different joint tissues, such as bone, cartilage, synovium, and tendon, contain and express ADAMTS-7, which colocalizes with ADAMTS-12 and COMP in the cytoplasm of chondrocytes. 62, 63 Consistent with this, we reported herein that cartilage-OA-SF co-cultures constitutively release COMP to the medium at significantly higher levels than cartilage-HD-SF co-cultures.
Tumor necrosis factor-a and IL-1b increase ADAMTS 7 and 12 mRNA in cartilage explants, 64 whereas ADAMTS-12 is not induced in human fetal fibroblasts. 57 We report, for the first time in SF, that IL-1b and Fn-fs promoted significant increases in ADAMTS-7 transcripts and protein levels, being greater in OA-than in HD-SF. Similarly, ADAMTS-12 transcripts and protein were stimulated by IL-1b and Fn-fs specifically in OA-SF. Interestingly, ADAMTS-12 was the only ADAMTS studied exclusively induced in OA-SF. Those facts are important for the development of combined therapies on the basis of the blockade of these ADAMTS. Emergent data indicate that ADAMTS-12 has multiple functions in the inflammatory response, 64 angiogenesis, and apoptosis.
65e67 Thus, further studies are needed to clarify whether ADAMTS-12 is also involved in those functions during OA development.
Our results showed that the stimulation of COMP release by IL-1b and Fn-fs was greater in OA-SF. Because specific antibodies against ADAMTS 7 and 12 inhibited the tumor necrosis factor-a-or IL-1beinduced COMP degradation in the cartilage of OA patients, 68 this increased release of COMP after IL-1b or Fn-fs treatment could be ascribed to the increased expression of both ADAMTS. Because, by contrast to ADAMTS-12, IL-1b and Fn-fs also induced ADAMTS-7 in HD-SF, COMP degradation may be mainly attributed to its action. Our data suggest that in the late phase of OA, IL-1b and Fn-fs may contribute to the damage of noncollagenous components of the ECM by increasing ADAMTS 7 and 12.
Our study presents two potential limitations. The in vitro model of cartilage-SF co-culture uses dead cartilage; thus, whether the same results would be obtained with SF adhered to live human OA cartilage is unknown. Besides, the medium used for all cell cultures was DMEM containing high glucose concentration. However, given that all treatments were performed with the same medium, this condition would not invalidate our results.
Overall, our data indicate that SF provides aggrecanases, ADAMTS-7, and ADAMTS-12 that contribute to the chronicity and destruction of OA joint. Although both IL-1b and Fn-fs have been described as mediators of cartilage degradation in OA, our findings indicate that despite the contribution of both mediators, they are Fn-fs rather than IL-1b, which plays the major pathological role, in agreement with recent studies. 12 We showed that constitutive levels of ADAMTS-4, one of the main aggrecanases in cartilage destruction, were higher in OA than in HD. Interestingly, the higher levels of ADAMTS-7 in OA compared to HD, as well as the regulation of ADAMTS-12 by IL-1b and Fn-fs exclusively in SF from OA patients, suggest their potential as new therapeutic targets for the treatment of the disease. Altogether, our results point to an important contribution of SF, providing the biochemical tools, to the chronicity and destruction of the osteoarthritic affected joint. 1430  1431  1432  1433  1434  1435  1436  1437  1438  1439  1440  1441  1442  1443  1444  1445  1446  1447  1448  1449  1450  1451  1452  1453  1454  1455  1456  1457  1458  1459  1460  1461  1462  1463  1464  1465  1466  1467  1468  1469  1470  1471  1472  1473  1474  1475  1476  1477  1478  1479  1480  1481  1482  1483  1484  1485  14861559  1560  1561  1562  1563  1564  1565  1566  1567  1568  1569  1570  1571  1572  1573  1574  1575  1576  1577  1578  1579  1580  1581  1582  1583  1584  1585  1586  1587  1588  1589  1590  1591  1592  1593  1594  1595  1596  1597  1598  1599  1600  1601  1602  1603  1604  1605  1606  1607  1608  1609  1610  1611  1612  1613  1614  1615  1616  1617  1618  1619  1620  1621  1622  1623  1624 
